Diamond DrugsJuly 20, 2018

FDA 145 - Diamond Drugs - July 20, 2018

FDA 145 for Diamond Drugs on July 20, 2018. Product: Drugs. Access full analysis and detailed observations.

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 145 for Diamond Drugs on July 20, 2018. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

FD&C Act 501(a)(2)(B)

21 U.S.C. 331(a)

21 CFR 211.100

21 CFR 211.22(a)

21 U.S.C. 352(f)(1)

21 CFR 211.25(a)

FD&C Act 502(f)(1)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Diamond Drugs

Inspection Date

July 20, 2018

Product Type

Drugs

People

Yvette I. Johnson (Compliance Officer)

ID: bbe4724b-585e-47b8-819b-8ce684b099f6

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox